Publicaciones en las que colabora con JOSÉ LUIS ARIAS MEDIANO (18)

2020

  1. Gemcitabine-loaded magnetically responsive poly(ε-caprolactone) nanoparticles against breast cancer

    Polymers, Vol. 12, Núm. 12, pp. 1-17

2018

  1. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy

    Colloids and Surfaces B: Biointerfaces, Vol. 171, pp. 553-565

  2. Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines

    Journal of Pharmacy and Pharmacology, Vol. 70, Núm. 4, pp. 488-497

2017

  1. Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs

    AAPS PharmSciTech, Vol. 18, Núm. 8, pp. 3042-3052

  2. Development of biomedical 5-fluorouracil nanoplatforms for colon cancer chemotherapy: Influence of process and formulation parameters

    International Journal of Pharmaceutics, Vol. 530, Núm. 1-2, pp. 155-164

  3. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil

    International Journal of Pharmaceutics, Vol. 516, Núm. 1-2, pp. 61-70

  4. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study

    European Journal of Pharmaceutical Sciences, Vol. 102, pp. 24-34

2016

  1. Magnetic solid lipid nanoparticles in hyperthermia against colon cancer

    International Journal of Pharmaceutics, Vol. 504, Núm. 1-2, pp. 11-19

2015

  1. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(Butylcyanoacrylate) nanoparticles

    International Journal of Nanomedicine, Vol. 10, pp. 1291-1306

  2. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles

    Drug Design, Development and Therapy, Vol. 9, pp. 6433-6444

  3. In vitro and in vivo evaluation of Δ9-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy

    International Journal of Pharmaceutics, Vol. 487, Núm. 1-2, pp. 205-212

  4. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer

    AAPS Journal, Vol. 17, Núm. 4, pp. 918-929

2014

  1. CO-99 Nanopartículas de Poli(ε-caprolactona) portadoras de 5-Fluorouracilo para mejorar el tratamiento del cáncer de colon avanzado

    I Congreso Nacional Multidisciplinar de Jóvenes Investigadores: libro de Actas : Facultad de Ciencias, Universidad de Granada 19, 20 y 21 de febrero de 2014 (Asociación de Investigadores Extranjeros (AINVEX)), pp. 227-232

2013

  1. Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing® for efficient antitumor activity

    International Journal of Pharmaceutics, Vol. 443, Núm. 1-2, pp. 103-109

  2. Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 85, Núm. 3 PART A, pp. 329-338

  3. RNA interference in the treatment of colon cancer

    BioDrugs, Vol. 27, Núm. 4, pp. 317-327

2012

  1. 5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

    International Journal of Nanomedicine, Vol. 7, pp. 95-107

  2. Doxorubicin-loaded nanoparticles: New advances in breast cancer therapy

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 12, Núm. 9, pp. 1058-1070